These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3839181)

  • 21. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor angiogenesis in women with node-positive breast cancer.
    Folkman J
    Cancer J Sci Am; 1995; 1(2):106-8. PubMed ID: 9166461
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical controlled trial in advanced breast cancer: CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CMF + T (cyclophosphamide, methotrexate, 5-fluorouracil, tamoxifen). CMEA Cooperative Treatment Group.
    Neoplasma; 1985; 32(3):381-7. PubMed ID: 2862594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Consensus and controversy in adjuvant treatment indications in breast cancers].
    Rouëssé J
    Pathol Biol (Paris); 1990 Oct; 38(8):846-7. PubMed ID: 2274383
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

  • 28. [Breast carcinoma in accessory gland: a case report].
    Sivelli R; Del Rio P; Arcuri MF; Corcione L
    G Chir; 2002 May; 23(5):179-80. PubMed ID: 12228967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer.
    Gordon NH; Silverman P; Lasheen W; Meinert J; Siminoff LA
    Breast Cancer Res Treat; 2007 May; 102(3):301-12. PubMed ID: 17033926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
    Mouridsen HT; Palshof T; Engelsman E; Sylvester R
    Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
    [No Abstract]   [Full Text] [Related]  

  • 31. Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
    Sanuki-Fujimoto N
    Cancer Treat Rev; 2005 Oct; 31(6):496-500. PubMed ID: 16199127
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adjuvant chemo and hormone therapy in breast cancer].
    Sauer H; Wilmanns W
    Chirurg; 1984 Apr; 55(4):207-10. PubMed ID: 6547086
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic adjuvant therapy and breast cancer.
    Rubens RD
    Radiother Oncol; 1985; 4(2):105-10. PubMed ID: 3934715
    [No Abstract]   [Full Text] [Related]  

  • 34. Dynamic hormonal chemotherapy in advanced metastatic breast carcinoma.
    Liu TJ
    Taiwan Yi Xue Hui Za Zhi; 1986 Apr; 85(4):376-83. PubMed ID: 3462321
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on.
    Mikl J; Aiginger P; Czerwenka K; Kubista E; Salzer H; Sevelda P; Spona J; Staffen A; Zielinski CC
    Lancet; 1990 Mar; 335(8688):541. PubMed ID: 1968551
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined therapy in advanced breast cancer.
    Davidson NE; Lippman ME
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1123-6. PubMed ID: 3000786
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adjuvant chemotherapy and chemo-hormonal therapy of breast cancer patients (a preliminary report)].
    Marinov L; Tsekova V; Koĭnov K; Velikova M; Rizova Kh
    Khirurgiia (Sofiia); 1986; 39(2):23-7. PubMed ID: 3735986
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjuvant therapy for premenopausal women with breast cancer: is it time for another paradigm shift?
    Pritchard KI
    J Clin Oncol; 2002 Dec; 20(24):4611-4. PubMed ID: 12488402
    [No Abstract]   [Full Text] [Related]  

  • 39. Osteopontin splice variants are differential predictors of breast cancer treatment responses.
    Zduniak K; Agrawal A; Agrawal S; Hossain MM; Ziolkowski P; Weber GF
    BMC Cancer; 2016 Jul; 16():441. PubMed ID: 27400751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy in breast cancer.
    Bonadonna G; Rossi A; Tancini G; Valagussa P
    Lancet; 1983 May; 1(8334):1157. PubMed ID: 6133169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.